MIV Therapeutics Inc. to Present at the BMO Capital Markets Focus On Healthcare Conference

ATLANTA--(BUSINESS WIRE)--MIV Therapeutics, Inc. (OTCBB: MIVI) (FWB: MIVN), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, today announced that Dr. Mark Landy, president and chief executive officer of MIV Therapeutics, will present a company overview at the BMO Capital Markets 2008 Focus On Healthcare Conference on Tuesday, August 5, 2008 at 3:00 p.m. Eastern time. The conference will be held at Millennium Broadway Hotel in New York City on August 5th and 6th.